Annual Total Expenses
$19.73 M
-$2.35 M-10.66%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual total expenses is $19.73 million, with the most recent change of -$2.35 million (-10.66%) on December 1, 2023.
- During the last 3 years, NBY annual total expenses has risen by +$3.37 million (+20.59%).
- NBY annual total expenses is now -22.76% below its all-time high of $25.54 million, reached on December 31, 2017.
Performance
NBY Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$3.50 M
+$49.00 K+1.42%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly total expenses is $3.50 million, with the most recent change of +$49.00 thousand (+1.42%) on September 1, 2024.
- Over the past year, NBY quarterly total expenses has increased by +$323.00 thousand (+10.16%).
- NBY quarterly total expenses is now -57.71% below its all-time high of $8.28 million, reached on December 1, 2023.
Performance
NBY Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
NBY Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.7% | +10.2% |
| 3 y3 years | +20.6% | -23.6% |
| 5 y5 years | -3.2% | -23.6% |
NBY Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.7% | +3.5% | -57.7% | +10.2% |
| 5 y | 5-year | -10.7% | +23.3% | -57.7% | +10.2% |
| alltime | all time | -22.8% | +1970.2% | -57.7% | +40.2% |
NovaBay Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.50 M(+1.4%) |
| Jun 2024 | - | $3.45 M(-17.8%) |
| Mar 2024 | - | $4.20 M(-49.3%) |
| Dec 2023 | $19.73 M(-10.7%) | $8.28 M(+160.5%) |
| Sep 2023 | - | $3.18 M(-30.7%) |
| Jun 2023 | - | $4.58 M(+24.5%) |
| Mar 2023 | - | $3.68 M(-41.8%) |
| Dec 2022 | $22.08 M(+15.8%) | $6.33 M(+47.8%) |
| Sep 2022 | - | $4.28 M(-26.3%) |
| Jun 2022 | - | $5.81 M(+2.8%) |
| Mar 2022 | - | $5.66 M(-11.2%) |
| Dec 2021 | $19.07 M(+16.5%) | $6.37 M(+39.8%) |
| Sep 2021 | - | $4.55 M(+14.1%) |
| Jun 2021 | - | $3.99 M(+20.0%) |
| Mar 2021 | - | $3.33 M(-8.7%) |
| Dec 2020 | $16.36 M(+2.3%) | $3.65 M(-13.8%) |
| Sep 2020 | - | $4.23 M(-16.3%) |
| Jun 2020 | - | $5.05 M(+47.5%) |
| Mar 2020 | - | $3.43 M(-13.1%) |
| Dec 2019 | $16.00 M(-21.5%) | $3.94 M(+18.5%) |
| Sep 2019 | - | $3.33 M(+5.0%) |
| Jun 2019 | - | $3.17 M(-43.0%) |
| Mar 2019 | - | $5.56 M(+6.2%) |
| Dec 2018 | $20.38 M(-20.2%) | $5.24 M(+5.8%) |
| Sep 2018 | - | $4.95 M(+1.5%) |
| Jun 2018 | - | $4.88 M(-8.2%) |
| Mar 2018 | - | $5.32 M(-10.3%) |
| Dec 2017 | $25.54 M(+11.6%) | $5.92 M(-5.4%) |
| Sep 2017 | - | $6.26 M(+6.5%) |
| Jun 2017 | - | $5.88 M(-21.4%) |
| Mar 2017 | - | $7.48 M(+22.4%) |
| Dec 2016 | $22.88 M(-10.3%) | $6.11 M(+11.1%) |
| Sep 2016 | - | $5.50 M(+12.2%) |
| Jun 2016 | - | $4.90 M(-23.0%) |
| Mar 2016 | - | $6.37 M(-19.4%) |
| Dec 2015 | $25.52 M | $7.90 M(+20.7%) |
| Sep 2015 | - | $6.55 M(+11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $5.87 M(+12.8%) |
| Mar 2015 | - | $5.20 M(-4.0%) |
| Dec 2014 | $17.96 M(-5.3%) | $5.42 M(+27.0%) |
| Sep 2014 | - | $4.26 M(+9.1%) |
| Jun 2014 | - | $3.91 M(-10.5%) |
| Mar 2014 | - | $4.37 M(-18.8%) |
| Dec 2013 | $18.96 M(+24.3%) | $5.38 M(+31.7%) |
| Sep 2013 | - | $4.08 M(-18.3%) |
| Jun 2013 | - | $5.00 M(+10.9%) |
| Mar 2013 | - | $4.51 M(+14.0%) |
| Dec 2012 | $15.26 M(-0.5%) | $3.96 M(+5.5%) |
| Sep 2012 | - | $3.75 M(+0.1%) |
| Jun 2012 | - | $3.75 M(-1.6%) |
| Mar 2012 | - | $3.81 M(+2.9%) |
| Dec 2011 | $15.34 M(+7.5%) | $3.70 M(+18.5%) |
| Sep 2011 | - | $3.12 M(-23.7%) |
| Jun 2011 | - | $4.09 M(-7.8%) |
| Mar 2011 | - | $4.43 M(+43.2%) |
| Dec 2010 | $14.27 M(+10.2%) | $3.10 M(-17.0%) |
| Sep 2010 | - | $3.73 M(-0.2%) |
| Jun 2010 | - | $3.74 M(+1.0%) |
| Mar 2010 | - | $3.70 M(-8.8%) |
| Dec 2009 | $12.94 M(-15.0%) | $4.06 M(+22.5%) |
| Sep 2009 | - | $3.31 M(+25.7%) |
| Jun 2009 | - | $2.63 M(-10.4%) |
| Mar 2009 | - | $2.94 M(-22.5%) |
| Dec 2008 | $15.23 M(+29.2%) | $3.79 M(+20.2%) |
| Sep 2008 | - | $3.16 M(-20.0%) |
| Jun 2008 | - | $3.95 M(-8.9%) |
| Mar 2008 | - | $4.33 M(+40.4%) |
| Dec 2007 | $11.79 M(+67.0%) | $3.08 M(+0.4%) |
| Sep 2007 | - | $3.07 M(-2.0%) |
| Jun 2007 | - | $3.13 M(+25.5%) |
| Mar 2007 | - | $2.50 M |
| Dec 2006 | $7.06 M(+97.8%) | - |
| Dec 2005 | $3.57 M(+274.5%) | - |
| Dec 2003 | $953.00 K | - |
FAQ
- What is NovaBay Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual total expenses year-on-year change?
- What is NovaBay Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly total expenses year-on-year change?
What is NovaBay Pharmaceuticals annual total expenses?
The current annual total expenses of NBY is $19.73 M
What is the all time high annual total expenses for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual total expenses is $25.54 M
What is NovaBay Pharmaceuticals annual total expenses year-on-year change?
Over the past year, NBY annual total expenses has changed by -$2.35 M (-10.66%)
What is NovaBay Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of NBY is $3.50 M
What is the all time high quarterly total expenses for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly total expenses is $8.28 M
What is NovaBay Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, NBY quarterly total expenses has changed by +$323.00 K (+10.16%)